Do you have COPD?
Ehrhardt Clinical Research currently has openings for our Pearl Therapeutics COPD study. This trial uses an oral medication for subjects suffering from Crohn’s Disease.
Basic Qualifications Include
- Male or female aged 18-75 at time of screening
- Have been diagnosed with Crohn’s Disease for at least 2 months
- Are currently experiencing symptom such as frequent stools, blood in stools and moderate to severe abdominal pain
- Have failed prior treatment with a biologic (such as Remicade, Humira), prednisone, or other treatment such as Lialda.
- Are willing to undergo a study paid for colonoscopy
If You Qualify You May Receive
- Treatment by licensed and experience GI physician
- Study provided medication
- Compensation for time and travel
If you are interested in this trial, please call us at 816-318-8488 or email us at info@ecrtrials.com or complete the Volunteer Interest Form today.
